+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand



Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand



Official Gazette of the United States Patent & Trademark Office Patents 1220(4): 3549, March 23




(PDF emailed within 1 workday: $29.90)

Accession: 035980202

Download citation: RISBibTeXText


Related references

Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor. Molecular Endocrinology 25(10): 1804-1818, 2012

Synthesis and receptor binding properties of chimeric peptides containing a mu-opioid receptor ligand and nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-amide. Bioorganic & Medicinal Chemistry Letters 16(18): 4839-4841, 2006

Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9(2): 208-218, 1995

Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking. Journal of Chemical Information and Modeling 48(3): 509-533, 2008

Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor. Fibrinolysis & Proteolysis 12(4): 219-240, 1998

Inhibition of gastrin-stimulated cell proliferation by the CCK-B/gastrin receptor ligand CI-988. Food & Chemical Toxicology 37(2-3): 105-110, Feb -March, 1999

Receptor-ligand interaction between vitellogenin receptor and vitellogenin , implications on low density lipoprotein receptor and apolipoprotein B/E The first three ligand-binding repeats of VtgR interact with the amino-terminal region of Vtg. Journal of Biological Chemistry 278(5): 2799-2806, January 31, 2003

Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling. Biopolymers 41(7): 799-817, 1997

The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain. Molecular Endocrinology 21(1): 30-48, 2006

Determining the parameters for receptor-ligand interaction by serial dilution method for the case when the ligand and receptor are in a pre-existing mixture. Ukrainskii Biokhimicheskii Zhurnal 77(4): 138-145, 2005

Determining the parameters for receptor-ligand interaction by serial dilution method for the case when the ligand and receptor are in a pre-existing mixture. Ukrains'kyi Biokhimichnyi Zhurnal 77(4): 138-145, 2006

Effects of SH-modifying reagents on the rat hepatic Ah receptor: inhibition of ligand binding and transformation, and disruption of the ligand-receptor complex. Biochimica et Biophysica Acta 964(3): 361-376, 1988

Ligand and receptor dependent sorting of internalized ligand between diacytosis and transport to lysosomes in asialoglycoprotein receptor mediated endocytosis. Journal of Cell Biology 107(6 PART 3): 549A, 1988

Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor. Journal of Biological Chemistry 289(9): 5704-5722, 2014

The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kappa B activation. Gastroenterology 126(1): 371-373, 2004